"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)
Refinement and Pilot Testing of the "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions in the Deep South (MyHP-South)
The goal of this clinical trial is to evaluate the feasibility and acceptability of the revised My Health Priorities (MyHP) program among rural and underserved older adults with multiple chronic conditions in the Deep South. The program is designed to help participants clarify their health-related values, as well as improve communication with family caregivers and healthcare providers to support medical decision-making. The main question this study aims to answer is whether the revised MyHP program is practical/easy for individuals to use, and if it helps support necessary conversations about healthcare priorities. Participants will be asked to complete the revised MyHP program over a Zoom or in-person session with their caregiver, as well as complete questionnaires over a telephone interview before and 12 weeks after the completion of the program. In addition to participating in the MyHP program, caregivers will also be asked to complete a series of questionnaires over a telephone interview before and 12 weeks after the program. Both patients and caregivers will also be asked to complete a brief survey about their experience with the program over a telephone interview.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Alexis M Johnson, B.S.
- Telefonnummer: 205-975-1864
- E-Mail: amjohns2@uab.edu
Studieren Sie die Kontaktsicherung
- Name: Deborah B Ejem, Ph.D.
- Telefonnummer: 205-996-1671
- E-Mail: tejem@uab.edu
Studienorte
-
-
Alabama
-
Birmingham, Alabama, Vereinigte Staaten, 35233
- The Whitaker Clinic of the University of Alabama at Birmingham (UAB) Hospital
-
Kontakt:
- Alexis M Johnson, B.S.
- Telefonnummer: 205-975-1864
- E-Mail: amjohns2@uab.edu
-
Kontakt:
- Deborah B Ejem, Ph.D.
- Telefonnummer: 205-996-1671
- E-Mail: tejem@uab.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria for Patients:
- Identifies as African American or White/Caucasian
- Is 65 years of age or older
- Has at least two of the following chronic conditions: cancer, heart disease, kidney disease, liver disease, or lung disease
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has a family caregiver that meets the eligibility requirements
- Has reliable telephone access
Inclusion Criteria for Caregivers:
- Identifies as African American or White/Caucasian
- Is 18 years of age or older
- A relative, partner, or friend who provides unpaid assistance or support with health-related decision-making (may or may not live in the same residence)
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has reliable telephone access
Exclusion Criteria for Patients:
- Has a documented diagnosis of dementia
- Is unable to understand the study and provide informed consent
- Resides in a nursing home or assisted living facility
Exclusion Criteria for Caregivers:
- Is unable to understand the study and provide informed consent
- Is unable to communicate with research staff
- Is unable to participate in the dyadic MyHP-South session and required assessments
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: MyHP-South Users
Includes the patients and caregivers who will be utilizing the MyHP-South program, as well as evaluating its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. This arm also includes the clinicians who will be assessing the usefulness of the program in a primary care setting. |
Participants will use the refined My Health Priorities South (MyHP-South) program to help identify and communicate personal health priorities, then evaluate its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Patient System Usability Scale (SUS)
Zeitfenster: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, patients will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
At the MyHP-South session, within 14 days after baseline.
|
|
Acceptability Interview
Zeitfenster: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, both patients and caregivers will together answer 26 questions regarding their experience using the revised MyHP-South tool. Answer options will be open-ended. |
At the MyHP-South session, within 14 days after baseline.
|
|
Recruitment Feasibility
Zeitfenster: From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
Indicated by the number and proportion of eligible patient-caregiver dyads who enroll. |
From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
|
Retention and Completion Feasibility
Zeitfenster: From baseline through 12 weeks after the MyHP-South session.
|
Indicated by the number and proportion of enrolled dyads completing baseline assessments, the MyHP-South session, immediate post-session assessments, the acceptability interview, and the 12-week assessments. |
From baseline through 12 weeks after the MyHP-South session.
|
|
Caregiver System Usability Scale (SUS)
Zeitfenster: Immediately after the MyHP-South session, during the same study visit.
|
Over a Zoom or telephone interview, caregivers will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
Immediately after the MyHP-South session, during the same study visit.
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
CollaboRATE Scale Score
Zeitfenster: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer three questions regarding their experience with their healthcare provider during a clinical encounter. Answer options will follow a ranked scale ranging from zero to nine and will then be calculated into a final score/percentage. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Treatment Burden Questionnaire (TBQ) Score
Zeitfenster: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 13 questions regarding the potential burden of managing multiple chronic conditions. Answer options will follow a ranked scale ranging from zero to ten and will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Patient Shared Care Instrument Score
Zeitfenster: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 19 questions regarding communication, decision making, and reciprocity with their caregiver. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Bakas Caregiver Outcomes Scale (BCOS)
Zeitfenster: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 10 questions regarding potential life changes that have occurred as a result of serving as a caregiver. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from -3: changed for the worse, to +3: changed for the best. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Older Patient Assessment of Chronic Illness Care (O-PACIC) Scale Score
Zeitfenster: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer ten questions regarding the quality of medical care they have received over the past six months. Answer options will follow a Likert-type frequency scale, which will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Caregiver Shared Care Instrument Score
Zeitfenster: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 19 questions regarding communication, decision making, and reciprocity with their patient. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
Andere Ergebnismessungen
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Timing Log for MyHP-South Session
Zeitfenster: At the MyHP-South session, within 14 days after baseline.
|
Research staff will document the length of each MyHP-South session by documenting what time the session started and what time the session ended. Time used to navigate technical difficulties will be subtracted. Tracking how long the session takes serves as a measure of feasibility. |
At the MyHP-South session, within 14 days after baseline.
|
|
Clinician Feedback Survey
Zeitfenster: Within 6 months after the completion of the MyHP-South session.
|
Over an electronic survey, clinicians who provide care to enrolled patients will answer ten questions regarding the clarity, fit, and usefulness of the revised MyHP-South in a primary care setting. |
Within 6 months after the completion of the MyHP-South session.
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Hauptermittler: Deborah B Ejem, Ph.D., University of Alabama at Birmingham
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- IRB-300016725
- U54AG093230 (US NIH Stipendium/Vertrag)
- 606877 (Andere Kennung: ASSIST Study ID)
- DGCG-11797 (Andere Kennung: NIA CROMS Study ID)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .